A global biotech company is entering the next phase of its construction of a $700 million pharmaceutical manufacturing-and-research flagship facility it's building in New Jersey.
A global biotech company is entering the next phase of its construction of a $700 million pharmaceutical manufacturing-and-research flagship facility it's building in New Jersey.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
55 Cambridge Pky, Cambridge, MA
1 meadowlands Plz, East Rutherford, NJ
Professional, Scientific, and Technical Services